Advisor Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $9.09M | Buy |
99,660
+10,741
| +12% | +$952K | 0.64% | 25 |
|
|
2022
Q1 | $7.3M | Buy |
88,919
+5,253
| +6% | +$414K | 0.46% | 38 |
|
|
2021
Q4 | $6.41M | Sell |
83,666
-1,456
| -2% | -$116K | 0.39% | 46 |
|
|
2021
Q3 | $6.39M | Sell |
85,122
-5,294
| -6% | -$403K | 0.43% | 45 |
|
|
2021
Q2 | $7.03M | Sell |
90,416
-7,485
| -8% | -$557K | 0.46% | 44 |
|
|
2021
Q1 | $7.2M | Sell |
97,901
-18,849
| -16% | -$1.39M | 0.52% | 38 |
|
|
2020
Q4 | $9.11M | Sell |
116,750
-5,157
| -4% | -$394K | 0.68% | 29 |
|
|
2020
Q3 | $9.65M | Buy |
121,907
+3,779
| +3% | +$296K | 0.83% | 19 |
|
|
2020
Q2 | $8.72M | Buy |
118,128
+4,856
| +4% | +$366K | 0.81% | 22 |
|
|
2020
Q1 | $8.32M | Buy |
113,272
+9,234
| +9% | +$726K | 1.01% | 16 |
|
|
2019
Q4 | $9.09M | Buy |
104,038
+8,680
| +9% | +$713K | 0.94% | 18 |
|
|
2019
Q3 | $7.66M | Buy |
95,358
+7,396
| +8% | +$593K | 0.93% | 18 |
|
|
2019
Q2 | $7.04M | Buy |
87,962
+1,695
| +2% | +$130K | 0.86% | 19 |
|
|
2019
Q1 | $6.85M | Buy |
86,267
+2,921
| +4% | +$218K | 0.88% | 21 |
|
|
2018
Q4 | $6.08M | Buy |
83,346
+7,141
| +9% | +$504K | 0.97% | 19 |
|
|
2018
Q3 | $5.16M | Buy |
76,205
+4,392
| +6% | +$280K | 0.69% | 23 |
|
|
2018
Q2 | $4.16M | Buy |
71,813
+8,967
| +14% | +$506K | 0.7% | 25 |
|
|
2018
Q1 | $3.27M | Buy |
62,846
+6,305
| +11% | +$341K | 0.6% | 34 |
|
|
2017
Q4 | $3.31M | Sell |
56,541
-6,427
| -10% | -$356K | 0.59% | 37 |
|
|
2017
Q3 | $3.85M | Sell |
62,968
-1,524
| -2% | -$92.4K | 0.76% | 24 |
|
|
2017
Q2 | $3.94M | Buy |
64,492
+5,772
| +10% | +$351K | 0.93% | 21 |
|
|
2017
Q1 | $3.56M | Buy |
58,720
+2,411
| +4% | +$146K | 0.95% | 22 |
|
|
2016
Q4 | $3.16M | Sell |
56,309
-938
| -2% | -$54.9K | 0.95% | 21 |
|
|
2016
Q3 | $3.41M | Buy |
57,247
+721
| +1% | +$42.2K | 1.14% | 15 |
|
|
2016
Q2 | $3.11M | Buy |
56,526
+1,502
| +3% | +$79.9K | 1.09% | 16 |
|
|
2016
Q1 | $2.78M | Sell |
55,024
-6,370
| -10% | -$312K | 1.03% | 19 |
|
|
2015
Q4 | $3.09M | Buy |
61,394
+5,290
| +9% | +$267K | 1.06% | 17 |
|
|
2015
Q3 | $2.67M | Buy |
56,104
+5,344
| +11% | +$284K | 1.12% | 16 |
|
|
2015
Q2 | $2.78M | Buy |
50,760
+4,405
| +10% | +$247K | 1.06% | 13 |
|
|
2015
Q1 | $2.54M | Buy |
46,355
+1,581
| +4% | +$89.5K | 1.08% | 10 |
|
|
2014
Q4 | $2.44M | Buy |
+44,774
| New | +$2.49M | 1.07% | 13 |
|
|
2014
Q3 | – | Sell |
-44,462
| Closed | -$2.45M | – | 259 |
|
|
2014
Q2 | $2.45M | Buy |
44,462
+1,541
| +4% | +$84.1K | 1.21% | 11 |
|
|
2014
Q1 | $2.33M | Buy |
42,921
+1,050
| +3% | +$54.4K | 1.28% | 12 |
|
|
2013
Q4 | $2M | Buy |
41,871
+2,569
| +7% | +$117K | 1.15% | 15 |
|
|
2013
Q3 | $1.78M | Buy |
39,302
+1,849
| +5% | +$84.4K | 1.28% | 14 |
|
|
2013
Q2 | $1.66M | Buy |
+37,453
| New | +$1.67M | 1.36% | 14 |
|
Other funds holding MRK
Advisor Partners's MRK Position: Q2 2022 in Review
Advisor Partners increased its Merck (MRK) stake by 12% in Q2 2022, buying an estimated $952K and bringing the position to 99,660 shares worth $9.09M. The position accounts for 0.64% of the portfolio, ranked #25.
Advisor Partners first reported a position in MRK in Q2 2013 and has held it in 36 quarters since. The position peaked at $9.65M in Q3 2020. 3,014 funds tracked by Wall St. Rank hold MRK as of Q2 2022.
- Advisor Partners held 99,660 shares of Merck worth $9.09M as of Q2 2022.
- Advisor Partners bought 10,741 Merck shares in Q2 2022, an estimated $952K.
- Merck made up 0.64% of Advisor Partners's portfolio in Q2 2022, its #25 holding.
- Advisor Partners first reported a position in Merck in Q2 2013 and has held it in 36 quarters since.
- Advisor Partners's Merck position peaked at $9.65M in Q3 2020.
- 3,014 funds tracked by Wall St. Rank held Merck as of Q2 2022.
Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.